CTLT  valuation analysis

Basics
Name: Catalent, Inc
Description: Catalent, Inc., together with its subsidiaries, provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 02, 2021
Market cap: $17.28B (229th)
Sales(TTM): $3.46B (335th)
Earnings(TTM): $345.90M (296th)

Value
FFER: 2.79*
Actual price: $101.57
* Earnings were reported May 03, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-05-12
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Catalent, Inc's sales grew by 26.9% ($2.73B to $3.46B) over one year against a market average growth of 3.5%.
Earnings / MarketCap
Catalent, Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
Catalent, Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
Catalent, Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
Catalent, Inc
"Drug Manufacturers-Specialty & Generic" industry